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The antigen specificity ofantiviral CTL isthought to betheresult ofTCR recog-
nition ofan antigenic polypeptide seen in associationwith aselfclass I MHC mole-
cule (1-3). The CTL epitope is controlled by the antigen, since CTL responses to
cell surface viral proteins discriminate between related viral antigens (4, 5) and the
class I molecule itself (6).
In addition to antigen-specific MHC-restricted CTL, CTL can be readilygener-
ated against allogeneic class I molecules. In general, -90% ofCTL directed against
a given alloantigen are specific for that molecule; whereas <10% ofCTL clones de-
rivedfrom a bulkpopulation crossreact on other class Imolecules (7, 8). This finding
is not unexpected since class I alloantigens differ from each other in -10% oftheir
amino acids. However, the same exquisite specificity is noted when CTL generated
against the H-2Kb molecule are tested against H-2Kb mutant antigens that differ
from the parental type by only one to three amino acids (9-12). For example, the
H-2Kbm1 mutant differs from the wild-type H-2Kb molecule at amino acid positions
152, 155, and 156 (13, 14). As a result of this change <259o' of anti-H-2Kb CTL
clones recognize this molecule (15). Similar findings are noted with CTL directed
against subtypes of HLA molecules (16, 17).
While most alloreactive CTL demonstrate this high degree of specificity, some
show greater than expected crossreactivity on third-party targets. Thus, anti-H-2d
CTL readily crossreact with H-2q antigens (18). Although the B6 anti-H-2Kbmr re-
sponse discriminates between other H-2Kb mutant molecules, it has been demon-
strated that these effector cellscrossreact with other H-2 molecules (19). The nature
ofthe antigenic determinants recognized byalloreactive T cells andthe mechanism
by which this fine specificity is achieved are poorly understood.
Recently, the structure ofthe class I antigen HLA-A2 was shown to comprise two
a-helical regions (20, 21). One ofthese regions is containedinthe al domain (amino
acids 50-84), the other in the a2 domain (amino acids 138-173). Both traverse a
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region of eight antiparallel 0-pleated sheets. Together, these a-helical regions form
a cleft on the apical surface of the molecule that is believed to be the site for binding
peptides. This raises the possibility that alloreactiveCTL recognize amino acids from
a peptide together with the foreign class I a helices.
Whether determinants recognized by alloreactiveCTL can be identified indepen-
dently in the al and a2 domains, or if together they form a conformational or non-
linear epitope, has been addressed by creating domain-shuffled class I molecules in
which the al and a2 domains are derived from two different class I molecules (22-28).
In most cases these domain-shuffled molecules are poorly recognized by CTL that
have been sensitized against either native molecule. Thus, these data would suggest
that alloreactive CTL recognize nonlinear epitopes. We have recently reported (29)
the generation of bulk-cultured CTL directed against determinants encoded by the
al and a2 extracellular domains of Q10d. These CTL crossreact extensively on three
different class I molecules from the H-2d haplotype (30). In this report we provide
evidence that this Q10-encoded epitope is controlled in part by three amino acids
in the a2-encodedhelix. However, recognition of this epitope is dependent on specific
amino acids in the a 1 domain.
Materials and Methods
Mice.
￿
C57BL/6, H-2Kbm1,s,5,6,s,io,i1
￿
C57BL/10, B10.D2(R103), B10.A(3R), (C3H x
B6.K1)Fj, (C3H x H-2Kbm1)F,, (C3H x BALB/c)FI, and (C3H x BALB/c-H-2dms)F1 mice
were bred and maintained in our colony at the University of 'Ibxas Southwestern Medical
Center at Dallas.
Maintenance of Transfected Cell Lines.
￿
Identification of the QIOd gene, construction of the
QIOdILd exon-shuffled class I gene, and transfection into L cells has been described previ-
ously (31). The Q10d/Ld- and HSVtk-expressing L cell lines were obtained from Drs. I.
Stroynowski and L. Hood at the California Institute of Technology, Pasadena, CA. Oligo-
nucleotide-directed mutagenesis of the H-2K6 gene to produce the revertant genes KIT,,-Ty.
(designated Glu(152) in this report) and KIAla (designated Arg-Leu(155-156) in this report)
and transfection of these genes into L cells have been described previously (32). Generation
of the mutant H-2Ld genes M66, M70, and M73 and transfection into L cells have been de-
scribed (33). The H-2Ld-, M66-, M70-, M73-, and H-2Dd-expressing L cells were obtained
from Drs. D. Koeller and K. Ozato at the National Institutesof Health, Bethesda, MD. Trans-
fected L cells were maintained in a-MEM (Irvine Scientific, SantaAna, CA) containing 5%
FCS, glutamine, and gentamicin. L cells were selected and maintainedin medium containing
HAT.
Generation and Assay of CTL Activity.
￿
Mice were primed in vivo with 107 Q10d/Ld-ex-
pressing L cells or 3 x 107 spleen cells intraperitoneally. After an interval of 3 wk to 3 mo,
5 x 106 spleen cells from primed mice were stimulated in vitro with 105 irradiated (10,000
rad) Q10d/Ld L cells or 5 x 106 irradiated spleen cells (2,000 rad). After 5 d of culture, effector
cell activity was tested using5'Cr-labeled L cells in a standard 4-h chromium-release assay.
Specific release equals the percentage of release of isotope from target cells in the presence
of effector cells minus spontaneous release. Spontaneous release from L cell targets ranged
between 5 and 15%, and from Con A lymphoblasts targets between 10 and 20%. SEM of
triplicate samples did not exceed 296.
Cloning of CTL.
￿
Anti-Q10 CTL clones were generated by priming (C3H x B6.K1)Fl
mice intraperitoneally with 107 Q10d/Ld L cells, followed by restimulation with the same L
cells in vitro. After 7 d ofculture the cells were placed into limiting dilution at multiple cell/well
concentrations in 96-well plates with 106 irradiated H-2Kbm' or BALB/c spleen cells. Cul-
tures contained a final concentration of 25 % rat Con A supernatant with a-methylmannoside.
Clones were picked, expanded, and subcloned at limiting dilution.Results
Anti-Q10 CTL Recognize H-2K".
￿
H-2K6'"1 is a mutant gene derived from H-Mb.
The mutation involves changes in 7 by that encode amino acid residues 152, 155,
and 156. It hasbeen suggested that this mutant maybe the result ofa gene conver-
sion event between Q& and H-Mb since the former gene shares H-2K" nucleo-
tides in the region where the mutation occurred (14, 34-36). Q10 is asecreted class
I molecule and cannot be tested directly as a target for CTL (36-38). However, by
shuffling the first three exons of Q10dwith the latter five exons ofH-2L", a hybrid
molecule can be expressed on the cell membrane oftransfected L cells containing
the al and a2 domains of Q10 together with the carboxy-end of the molecule de-
rived from H-2Ld (31) . We recently showed CTL activity can be generated against
this molecule and it is specific for determinants controlled by the al and a2 and
not the H-2Ld-encoded 0 domain (29, 30). Since Q10 shares the H-2Kbm1 mutant
amino acids at positions 152, 155, and 156 (see Table III), we tested whether anti-
Q10 CTL would crossreact on H-2Kbm',
Anti-Q10 CTL were generated by stimulating spleen cells from (C3H x B6.K1)F1
(K''D'F/KbDb) mice with L cells (H-2k) expressing the Q10d/Ldhybrid molecule. The
resulting CTL were tested for reactivity against Q10d/Ld-transfected L cells, H-2Kb'"'
lymphoblasts, or target cellsderived from a panelofH-2Kb mutant strains including
H-2Kbm3,5,6,8,10,11. These other mutant strains have amino acid substitutions in the
H-2Kb molecule at sites that differ from H-2Kbml (9, 10). The data in Fig. 1 (left
pano show that anti-Q10 CTLmediate specific lysis against Q10-transfected L cells
with only weak lysis ofL cells transfected with the tk gene, as previously described
(29, 30). The same effector cells also display strong lytic activity against H-2Kbm'
targets, while little or no reactivity is detected on any ofthe other H-2Kb mutants
(Fig. 1, rightpano. Thus, anti-Q10-specific CTL crossreact on the H-2K" mole-
cule that shares an alanine and two tyrosines at amino acid positions 152, 155, and
156, respectively, with Q10 (see Table III).
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FIGURE 1 . Anti-Q10 CTL
crossreact on H-2K6". (C3H
x B6.K1)F1 mice were primed
in vivo with Q10d/Ld L cells
followed by restimulationwith
the same cells in vitro. Specific
release of 51Cr from tk and
Q10d/Ldtransfected Lcells left
panno or H-2Kbm1,s,5,6,e,1 ,11
ConAlymphoblasts (rightpan-
el) is indicated. Note that
H-2Kbme,1o,11 targets had the
same level of lysis andthus are
denoted by the same symbol.310
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FIGURE 2.
￿
Anti-H-2Kbm1 CTL crossreact on Q10d/Ld and
H-2Ld. B6 spleen cells were stimulated in vitro with
H-2Kbm1 spleen cells. Specific release of "Cr from tk,
H-2kbmr, QIOd/Ld, and H-2Ld transfected L cells is in-
dicated.
B6 Anti-H-2K" CTL Crossreact with QIVILd and H-2Ld.
￿
The above data dem-
onstrate antigenic crossreactivity between Q10d and H-2Kbm1 . In addition, cross-
reactivity between H-2Kbm1 and a D end-encoded molecule from the H-2d haplo-
type has been observed (39). It has also been noted that the H-2Ld molecule has
the same sequence as H-2Kbm1 at the mutant amino acid positions 152, 155, and
156 and evidence has been provided that anti-H-2Ld CTL crossreact on H-2Kbml
(40, 41). We previously showed that anti-H-2Ld CTL crossreact on Q10d (29).
Thus, anti-H-2Ld CTL appear to have a subset of cells capable of recognizing both
H-2Kbm1 and Q10d. The reactivity of B6 anti-H-2Kbm1 CTL on H-2Ld targets has
been examined using a monolayer absorption technique and two subpopulations
of CTL were detected directed at H-2d targets (19). One apparently recognized
H-2Ld while the second recognized another H-2d-encoded molecule, possibly
H-2Kd .
Based on the above studies, we reasoned that B6 anti-H-2Kbm1 CTL would cross-
react on Q10d and thus tested these effector cells for reactivity on H-W, H-2Kb"'',
H-2Ld, and Q10d/Ld L cells. B6 anti-H-2kbm1 CTL specifically lyse H-2Kbm1 L cells
(Fig. 2). In addition, a lesser amount of lysis was noted on both H-2Ld- and
QlOd/Ld-expressing targets. This weaker lysis is consistent with a subset of the B6
anti-H-2Kbmt CTL population being crossreactive. Thus, within the repertoire of
B6 anti-H-2Kbm1 CTL there exist populations that recognize H-2Ld , Q10d/Ld, and
another H-2d-encoded MHC molecule, possibly H-2Kd.
Anti-Q10 CTL Recognition ofH-2K" is Affected by Mutations at Both Positions 152 and
155-156. Since the H-2Kbm1 mutation is a complex event involving three amino
acid substitutions, it is not possible to distinguish which of these changes controls
the immunodominant epitope recognized by anti-Q10 CTL. To address this, anti-
Q10 CTL were tested for their ability to recognize H-2Kbm1 molecules in which
amino acid position 152 or 155 and 156 were changed back to the wild-type H-2Kb
residue by site-directed mutagenesis. The data in Fig. 3 indicate that the presencew N
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FIGURE 3.
￿
Anti-Q10 CTL do not recognize H-2Kb-I rever-
tant molecules. (C3H x B6.K1)FI mice were primed in vivo
with Q10d/Ld L cells followed by restimulation with the same
L cells in vitro. Specific releaseof5ICr from H-2K1, H-2A""',
Glu(152), andArg-Leu(155-156) transfected Lcellsis indicated.
ofthe H-2Kb residue glutamic acid rather than alanine at position 152 eliminates
recognition of H-2Kb-I by anti-Q10d CTL. Similarly, the presence of H-2Kb
residues arginine and leucine rather than tyrosines at positions 155 and 156 also
results in a loss of recognition. It should be noted that both revertant cell lines ex-
press equivalent amounts ofantigen as that ofH-2Kb- and H-2Kbm1-expressing L
celllines, asdetermined byRIA (32) andcytofluorimetry (datanotshown). Inaddi-
tion, both revertant cell lines are lysed by B6 anti-H-2Kb-1 CTL (32). The back-
ground lysis seen on H-2Kb is aphenomenon observed by us and otherinvestigators
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￿
(C3H x H-2Kb,I)FI
anti-Q10 CTL do not recognize
H-2d targets. (C3H x H-2Kbm')FI
mice were primed in vivo with
Q10d/Ld L cells followed by re-
stimulation with the same cells in
vitro. Specific release of 51Cr from
tk andQ10d/Ld transfected L cells
(kftpanel) or B10.D2(R103) (KdDb),
B10.A(3R) (KbDdL~, BALB.B
(KbD'), and BALB.K (KAD~ Con
Alymphoblasts (rightfianeo is indi-
cated. Note that BALB.B and
BALB.K targetshadthesamelevel
oflysis andthus aredenotedby the
same symbol.312
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(C3H x BALB/c)Fl
anti-Q10 CTL demonstrate
weak reactivity on H-2Kbm 1
targets . (C3H x BALB/c)FI
mice were primed in vivo with
Q10d/Ld L cells followed by re-
stimulation with the same L
cells in vitro. Specific release of
51Cr from tk andQ10d1Ld trans-
fected L cells (kft panel) or H-
2Kbm1 and B10 Con A lym-
phoblasts (right paneo is in-
dicated.
and is especially notedwhen effector cells are takenfrom animals previouslyprimed
in vivo with L cell transfectants (29, 30, 42) . This lytic activity is not specific for
H-2Kb since equivalent lysis is also detected on L cells tmnsfected with the tk gene
only (data not shown) . Thus, the recognition ofH-2Kbm1 by anti-Q10 CTL requires
the mutant amino acids at both positions 152 and 155-156 .
Animals Tolerant to H-2K6" do not Generate anti-Q10 CTL that Crossreact on H-2d An-
tigens. The previous data indicate that anti-Q10 CTL crossreact on H-2Kbml . We
have previouslyshown that these CTL recognize H-2Kd, H-2Ld, and a third H-2"-
encoded molecule controlled by a gene mapping between H-2D' and H-2V (30) .
To further establish the existence of a common epitope in multiple class I alloan-
tigens recognized by anti-Q10 CTL, CTL were generated using responder spleen
cells from (C3H x H-2Kbm 1)F l mice . We reasoned that only a portion of the anti-
Q10CTL response would be directed at the common epitope controlled by the amino
acids at positions 152, 155, and 156 . Thus, by removing the subset ofCTL reactive
against this epitope (by using mice expected to be tolerant to this determinant), a
loss of crossreactivity against other molecules containing the postulated common
epitope should occur . The data in Fig . 4 show that (C3H x H-2Kbm 1)F l mice
generate anti-Q10-specific CTL activity, as evidenced by lysis of Q10d/Ld L cell
targets (left panes . However, reactivity on H-2Kd-expressing B10.D2(R103) (K"D')
and H-2Ld-expressing B10.A(3R) (KIDdL~ target cells does not occur (right paneo .
In addition, H-2Kbm1 targets are not lysed (data not shown) . Thus, tolerance to
H-2Kbm1 results in a loss of reactivity to the other H-2d-encoded crossreactive an-
tigens .
In a reciprocal fashion, anti-Q10CTL were generated using spleen cells from (C3H
x BALB/c)Fi responders. The data in Fig. 5 show thesemice capable of generating
an anti-Q10-specific response by killing Q10d/Ld L cell targets (leftpanes . However,
reactivity on H-2K11 target cells is greatly reduced (right paneo . Thus, these data
support the postulate that H-2d molecules, H-2Kbm 1 , and Q10d share a common
epitope defined in part by amino acids 152, 155, and 156 .12 25 50 100
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FIouRE 6. (C3H x BALB/c-
H-2am2)Fl anti-Q10 CTL dem-
onstrate strong reactivity on
H-2Kbm1 and H-2d targets.
(C3H x BALB/c-H-2dm2)F1
mice were primed in vivo with
Ql0d/ Ld L cells followed by
restimulation with the same L
cells in vitro. Specific release of
"Cr from tk and QIMILd L
cells(kfipane0 or B10.D2(R103),
B10.A(3R), H-2Kbm1 and
BALB.B Con A lymphoblasts
(right panes is indicated.
We further tested whether (C3H x BALB/c-H-2dm2)Ft mice could generate anti-
Q10 CTL that crossreact on H-2Ld and H-2Kbmt . While BALB/c-H-2dm2 (KdD~
mice have deleted the H-2V gene (43), they do express H-2K' that shares tyrosines
at positions 155 and 156 with Q10. The data in Fig. 6 indicate that cells from these
mice generate strong lytic activity on H-2Kbmt_ and H-20-expressing B10.A(3R)
targets (right panel). Since H-2Kd differs from H-2Ld and H-2Kbmt at position 152
in that H-2K1 encodes an aspartic acid rather than an alanine, this suggests that
this residue has a significant effect on the recognition of the crossreactive epitope.
However, it should also be noted that all three of these molecules have other amino
acid differences, particularly in the al domain, as will be discussed later.
Specificity ofAnti-QlUt CTL Clones.
￿
Although the data presented indicate that the
presence of certain amino acids at positions 152, 155, and 156 coincides with Q10
crossreactivity, it is not clear whether the same CTL receptor interacts with each
alloantigen. Thus, it is possible that different CTL subsets are involved in the recog-
nition of each molecule. To resolve this, anti-Q10d bulk CTL cultures were cloned
by limiting dilution on H-2Kb-1 or BALB/c feeder cells. This approach was neces-
sary since attempts to clone and maintain long-term lines using L cell stimulators
were unsuccessful.
The lytic activity of the clones generated were tested on a panel of target cells
and grouped into four patterns of reactivity. The data in Fig. 7 indicate that group
I clones show significant lysis of H-2K'mi and Q10d/Ld-transfected L cells, but only
marginal recognition of H-2Ld. Group II clones exhibit reactivity on H-20 and
Q10'/L', but do not lyse H-2Kbmt targets. Group III clones exhibit reactivity on
H-2Kbm1-, H-2Ld-, and Q10d/Ld-expressing targets. Ofparticular interest is the re-
activity ofgroup IV clones. These clones have strong reactivity on L cells expressing
H-2Kbmt, H-2Ld, or Q10d/Ld molecules, and weak reactivity on H-2Dd. In addi-
tion, they recognize H-2Kd since they lyse B10.D2(R103) (Kd/DI) but not B10
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FIGURE 7. Anti-Q10 CTL clones demonstrate multiple crossreactivity patterns. (C3H x
B6.K1)FI anti-Q10 CTL clones were maintained on H-2Kb,I or H-2d stimulator cells. Specific
release of 5ICr from tk, QIOdlLd, H-2Kbe"l, and H-2Dd transfected L cells is indicated.
Effector/targetratiois 25:1. Each groupconsists of multiple anti-Q10 CTLclones with thesame
reactivity pattern. A representative from each group is shown in the figure.
(K'ID') Con A lymphoblasts (data not shown). Thus, this group of clones has a
specificity closest to that observed in the bulk population, although it does display
weak reactivity towards H-2Dd. The reactivity patterns of the anti-Q10 clones are
summarized in Table I. It was also noted that group I, III, and IV clones do not
react on the H-Mb-I revertant molecules Glu(152) and Arg-Leu(155-156), as ex-
pected (data not shown). While these data demonstrates that individual anti-Q10
CTL clones crossreact on multiple class I molecules, many ofthe clones do not recog-
nize all of the antigens carrying the Q10 sequence at positions 152, 155, and 156;
e.g., note that group I clones do not react on H-2L'. Thus, these data suggest that
other amino acids in class I molecules influence recognition.
Changes in the Sequence ofthe al Helix between Positions 63 and 73 ofH-2Ld Affects Rec-
ognition by anti-Q10 CTL Clones. The data thus far describe a CTL epitope con-
trolled by amino acids 152, 155, and 156 in the a2 domain. This epitope can be
recognized by bulk and cloned anti-Q10 CTL and is present in multiple class IMANN ET AL.
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TABLE I
Reactivity Patterns ofAnti-Q10 CTL Clones
+, Strong reactivity; -, no reactivity. R103 and B10 columns represent reactivity on
B10.D2(R103) and BIO Con A lymphoblast targets. The Kb"',Glu(152), Arg-Leu(155-6), Ld,
QI0, M66, M70, M73, Dd, and Ltk columns represent reactivity on L cells transfected with
the H-2Kb", Glu(152), Arg-Leu(155-6), H-2Ld, QIOd/Ld, M66, M70, M73, H-2Dd, and HSV-
ik genes, respectively. Note that each group represents multiple clones exhibiting the same reac-
tivity pattern. Na, not applicable.
molecules; i.e., H-2Kbmt, H-2Ld, H-2Kd, and Q10d/Ld. Recently, we reported the
influence ofamino acids in the a1 domain ofH-2Dd (from positions 63-73) in con-
trolling CTL epitopes recognized by anti-H-2Dd CTL (33). Site-directed mutagen-
esis was used to introduce H-2Dd-specific codons into the second exon (encoding
the a1 domain) of H-2Ld. L cell lines transfected with these mutant H-2Ld genes
were used in this study to assess the contribution ofthe a1 domain in the recogni-
tion of H-2Ld by anti-Q10 CTL.
The panel ofanti-Q10 CTL clones were tested for their ability to recognize three
independent H-2Ld mutant molecules. M66 acquired H-2Dd amino acids at posi-
tions 63, 65, and 66; M70 acquired an additional H-2Dd amino acid at position
70; and M73 included H-2D'-specific changes at positions 63, 65, 66, 70, and 73
(Table II). The effect of these various amino acid substitutions on the recognition
ofH-2Ld by anti-Q10 CTL correlates with the crossreactivity patterns ofthe var-
ious groups ofanti-Q10 CTL clones. Thus, group I clones display marginal lysis
of wild-type H-2Ld cells and no lysis of M66 or H-2Dd-expressing L cell targets
(Fig. 8). However, this group does crossreact on the mutants M70 and M73.
H-2Kbm1, Q10d, and H-2Dd have identical amino acids at positions 63, 70, and 73,
and at position 66, Q10d and H-2Dd have an arginine while H-2Kbmt has a lysine
(Table II). Thus, introducing changes into the H-2Ld moleculeto produce M70 and
M73 makes H-2Ld more homologous to H-2K" and Q10d and allows H-2Ld to
gain the crossreactive epitope. CTL clones from groups II and III, which react on
H-2Ld and Q10d/Ld, do not react on the M66 mutant cellline. However, they show
strong reactivity on the M70 and M73 mutant cell lines. This suggests that the in-
troduction ofthe changes at positions 63, 65, and 66 causes a loss ofthe H-2Ld (a2
domain-controlled) epitopethat can berestored byan additionalamino acidsubsti-
tution at position 70. The additional change atposition 73 has no discernable effect.
Group IV CTL clones, which crossreact on H-2Kbm1, H-2Ld, H-2Kd, and QIOd/Ld,
show strong reactivity on M66, M70, and M73 celllines. Thus, the recognition of
H-2Ld by this group is not influenced by H-2Dd-specific amino acid substitutions
in the al domain. These clones do, however, exhibit weak activity on H-2D1, as
previously noted. Taken together, these data show that while amino acids at posi-
Group R103 B10 Kbad
Glu
(152)
Arg-Leu
155/6
Target cells
Q10 Ld M66 M70 M73 Dd Ltk
I - - + - - + - - + + - -
II - - - NA NA + + - + + - -
III - - + - - + + - + + - -
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￿
Anti-Q10 CTL recognition of H-2L' is differentially affected by al domain substi-
tutions. (C3H x $6.K1)FI anti-Q10 CTL clones were maintained on H-2Kb,I or H-2dstimu-
lator cells. Specific release of51Cr from tk, H-2Ld, M66, M70, and M73 transfected L cells is
indicated. Effector/target ratio is 25:1. Each group consists ofmultiple anti-Q10CTL clones with
the same reactivity pattern. A representative of each group is shown in the figure.
tions 152, 155, and 156 controlthe expression oftheQ10crossreactive epitope, other
amino acids in the al helix also influence this determinant.
Discussion
We haveshownthatbulk-cultured CTL generatedagainstthehybrid classI mole-
cule Q10d/Ld crossreact on H-2Kbm1, H-W, and H-W. This finding was con-
firmed bydemonstratingthatCTLclones derivedfromthesebulk culturesdisplayed
a similar specificity. Since H-2Kbm1 revertant molecules that have amino acids at
positions 152 or 155 and 156 changed back to the wild-type H-2Kb residues are not
recognized by these CTL, this reactivity coincides with the presence ofan alanine
or aspartic acid (in the case of H-2Kd) at position 152 and tyrosines at positions
155 and 156 in the a2 helical region in all four ofthese molecules. Supportfor the
presence ofthis common epitope alsocomesfrom thedemonstration both byus and
others that anti-H-2Klbm1 CTL crossreact on H-2Ld, Q10d/Ld, and H-2Kd and the
finding that anti-H-2Ld CTL recognize both Q10d/Ld and H-2Kbmt (19, 29, 40, 41).318
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Thethree-dimensional structure ofthe human class I molecule HLA-A2 hasbeen
recently shown to have a surfaceconsisting oftwo antiparallel a-helical regions over-
laying eight R-pleated strands. It has been suggested that residues in the helices, to-
gether with particular amino acids on thestrands, are involved in binding antigenic
peptides and/or the TCR receptor (20, 21). The a2 domain-encoded helix consists
of amino acid residues 138-173, which includes positions 152, 155, and 156. Some
of the CTL-defined HLA class I variants have amino acid substitutions in this re-
gion (16, 17). HLA-A3.2 varies from the HLA-A3 .1 molecule at positions 152 and
156 and the substitution at residue 152 has been shown to profoundly affect how
these molecules arerecognized by both alloreactive and MHC-restricted CTL (44).
Thus, in both mouse and man substitutions involving residues 152, 155, and 156
affect particular CTL epitopes. To furtherunderscore the role of these amino acids
in controlling CTL determinants, it should be notedthat the H-2 class I molecules
containing the Q10crossreactive epitopevary considerably. Forexample, Q10 differs
from H-2Kbm', H-2Ld, and H-2Kd, by 26, 25, and 39%, respectively, of amino
acids contained in thetwo helices and R strands. Theseamino acidsrepresent residues
that could potentially contact an antigenic peptide or TCR (21) (see Tables II and
III). Further, approximately half of these differences represent amino acids with a
variability index greater than six (45) (see Tables II and III).
Polymorphic determinants recognized by alloreactive CTL have been mapped to
the al and a2 external domains of class I molecules (22, 46, 47). H-2 antigens con-
sisting of al and a2 domains derived from different class I molecules have been
createdin an attempt to determinewhether CTL determinants arelinear structures
in either a1 or a2, or nonlineardependent on aminoacids from both domains. When
this was studied using H-2Dd and H-2Ld domain-shuffled molecules, it was noted
that anti-H-213d and anti-H-W CTL recognized a construct consisting of Dd
amino acids in the al and Ld amino acids in the a2 domain (26). This finding sug-
gests that H-2Dd-specific epitopes are primarily controlled by the al domain;
whereas H-2Ld epitopes, including the Q10 crossreactive epitope described here, are
controlled primarily by amino acids in the a2 domain. This is supported by the
finding that the reciprocal Ld/Dd domain-shuffled molecule was recognized by nei-
ther anti-H-213d or anti-H-2Ld CTL (27). Recently, we further defined the impor-
tance of amino acid residues 63-73 in controlling H-2Dd CTL epitopes by showing
that changing amino acids in this region of the H-2Ld molecule to the H-2Dd type
allowed these mutant molecules to be recognized by anti-H-213d CTL (33).
H-2Ld epitopes have also been localized to the a2 domain by demonstrating that
anti-H-W CTL recognize the recombinant molecule H-2dm1 which contains Dd
amino acids in the al and NH2-terminal end of the a2 domain and Ld amino acids
in the COOH-terminal end of a2 (48, 49). We have noted that anti-Q10 CTL have
a similar reactivity against H-2dm1 (30).
Since most otherdomain-shuffled class I molecules are notrecognized by alloreactive
CTL (22-25, 27), it is likely in the above-mentioned examples that al domain
H-2d amino acids are permissive for the expression of H-2Ld a2 domain epitopes
and vice versa. The data presented in this study not only support this possibility
but identify specific amino acids in the al helix that control the expression of the
Q10 crossreactive epitope. For example, although group I anti-Q10 clones margi-
nally recognize H-2Ld, they do react with H-2Ldmutant moleculesthat have H-2Ddw
a
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amino acid substitutions at position 63, 65, 66, and 70 of the al domain. Groups
II and III clones, which crossreact on H-21,d' were negatively influenced by substi-
tutions in the al domain with a resulting loss of H-2Ld recognition. Thus, while
CTL epitopes may appear to be mapped solely to amino acids present in the al
or a2 domain-encoded a helices, the data presented in this report demonstrate that
a2 domain epitopes are dramatically affected by alteration ofamino acids in the a1
domain.
Using computer-aided modeling, the spatial positioning of Q10 residues relative
to HLA-A2 was found to be quite similar(P Bjorkman, personal communication).
However, there is an effect on the size ofthe proposed antigen-binding cleft between
the two helices in that the tyrosine residues at positions 155 and 156 in Q10 have
significantly larger side chains than the glutamine and leucine residues present in
the HLA-A2 molecule. Since these residues point down and into the cleft in both
Q10 and HLA-A2, the tyrosines in Q10 reduce the size of the pocket in this region.
Further, aminoacids at positions 97 (tryptophan), 99 (tyrosine), 159 (tyrosine), and
167 (tryptophan) allhave largeside chains, and due to their orientation in thegroove,
also tend to reduce its size (see Table III). It is interesting to note that unlike
H-2Kb, the H-2Kbm1 molecule (which has tyrosines at positions 155 and 156) does
not function as arestricting element formost antigens that have been tested (50-52).
It is possible that H-2Kbml with areduced groove size can no longer bind antigenic
peptides, especially ifthey requirean a-helical conformation, as previously suggested
(53-55). Alternatively, the size of the Q10 pocket maylimit the number of peptides
capable ofbinding to this class I molecule or allow for peptides to bind with a linear
rather than a-helical configuration.
It has been proposed that alloreactive CTL may recognize class I molecules to-
gether with self peptides that occupy these pockets (21). If the Q10 molecule has a
smaller peptide binding cleft, then it is possible that a relatively large proportion
of cell membrane Q10d/Ld molecules lack self peptides. This would tend to make
CTL recognition of Q10 specific for amino acids on the two helices, directly. Thus,
this mayexplainthe strong influenceof theresidue at position 155, whose side chain
is oriented in the presumed direction of the TCR, and residue 152, which should
have a similar orientation on the a helix, in controlling the crossreactive epitope.
Summary
CTL derived from (C3H x B6.K1)Fl animals were sensitized against L cells that
express the transfected gene product Q10d/Ld. These CTL were highly crossreac-
tive against three other class I molecules, H-2Kbm1, H-W, and H-2K'. In an at-
tempt to define this crossreactive epitope it was noted that between 25 and 39%
of amino acids in the a helices and central R strands of these three molecules vary
from Q10d. These amino acids represent residues that have been proposed to poten-
tially interact with a peptideantigen or TCR(21). However, all four molecules share
the amino acid tyrosine at positions 155 and 156. Additionally, Q10d, H-2Kbm1, and
H-2Ld share alanine at position 152, while H-2Kd has an aspartic acid. We showed
that these residues were important in controlling this epitope by the finding that
anti-Q10d CTL did not recognize H-2Kbm1 revertant molecules that had either the
position 152 alanine changed back to the wild-type H-2Kb residue (glutamic acid)
or position 155 and 156 tyrosines changed back to wild-type residues arginine andleucine. Further evidence that these molecules share a crossreactive epitope was noted
by the failure of (C3H x H-2Kbmt)Fl animals to generate CTL that recognized
H-2L' or H-2K, and the inability of(C3H x BALB/c)Fi animals to generate CTL
reactive against H-2Kbmt. CTL from these mice were still able to recognize Q10d/Ld
indicatingthat other epitopes could be detected if natural tolerance prevented recog-
nition of the crossreactive epitope. To further define the epitope, CTL clones were
generated against Q10d/Ld and maintained on either H-2Kb" or BALB/c feeder
cells. In addition to testing these clones on the target cells described above, mutant
molecules derived from H-2Ld, which have amino acid substitutions in their al do-
main, were analyzed. It was noted that some anti-Q10 clones that did not crossreact
on H-2Ld did react against H-2Ld mutant antigens that had H-213d amino acid sub-
stitutions in the al domain at positions 63, 65, 66, and 70. Other clones had differen-
tial reactivities on these H-2Ld mutants further substantiating that al domain
amino acids play a role in controlling the expression of the crossreactive epitope.
Thus, four class I molecules with multiple amino acid differences in their a1 and
a2 domains share a crossreactive epitope readily recognized by alloreactive CTL.
This epitope is dependent on the presence of amino acids at positions 152, 155, and
156 in the a2 helix as well as amino acids between residues 63 and 73 in the al helix.
The role ofthese residues in defining the nature ofthis alloreactive epitope is discussed.
Receivedforpublication 22 February 1988.
MANN ET AL.
￿
321
References
1 . Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J.
McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T
lymphocytes can be defined with short synthetic peptides. Cell. 44:959.
2. McMichael, A. J., F M. Gotch, andJ. Rothbard. 1986. HLA B37 determines an influenza
A virus nucleoprotein epitope recognized by cytotoxic T Lymphocytes. J. Exp. Med.
164:1397.
3 . T. J . Braciale, V. L. Braciale, M. Winkler, I. Stroynowski, L. Hood, J. Sambrook, and
M. J . Gething. 1987. On the role of the transmembrane anchor sequence of influenza
hemagglutinin in target cell recognition by classI MHC-restricted, hemagglutinin-specific
cytolytic T lymphocytes. J. Exp. Med. 166:678.
4. Yewdell, J. W., J. R. Bennick, M. Mackett, L. Lefrancois, D. S. Lyles, and B. Moss.
1986. Recognition of cloned vesicular stomatitis virus internal and external gene prod-
ucts by cytotoxic T lymphocytes. J. Exp. Med. 163:1529.
5 . Townsend, A. R. M., A. J. McMichael, N. P Carter, J. A. Huddleston, and G. G.
Brownlee. 1984. Cytotoxic T cell recognition ofthe influenza nucleoprotein and hemag-
glutinin expressed in transfected mouse L cells. Cell. 39:13 .
6. Zinkernagel, R. M., and P. C . Doherty. 1979. MHC-restricted cytotoxic T cells. Studies
on the biological role of polymorphic major transplantation antigens determining T cell
restriction specificity function and responsiveness. Adv. Immunol. 27:51.
7 . Taswell, C., H. R. MacDonald, and J.-C. Cerottini. 1980. Clonal analysis of cytolytic
T lymphocyte specificity. 1. Phenotypically distinct sets of clones as the cellular basis
of cross-reactivity to alloantigens. J. Exp. Med. 151:1372.
8. Lindahl, K. F, and D. B. Wilson. 1977. Histocompatability antigen-activated cytotoxic
T lymphocytes. II. Estimates ofthe frequency and specificity of precursors.J. Exp. Med.
145:508.322
￿
STRUCTURE OF A CYTOTOXIC T LYMPHOCYTE EPITOPE
9. Nairn, R., K. Yamaga, and S. G. Nathenson. 1980. Biochemistr y of the gene products
from murine MHC mutants. Annu. Rev. Genet. 14:241 .
10. Nathenson, S. G., J. Geliebter, G. M. Pfaffenbach, and R. A. Zef. 1986. Murine major
histocompatibility complex class I mutants: molecular analysis and structure-function
implications. Annu. Rev. Immunol. 4:471.
11 . Melief, C. J. M., L. D. De Waal, M. Y Van Der Meulen, R. W Melvold, and H. I.
Kohn. 1980. Fine specificity of alloimmune cytotoxic T lymphocytes directed against
H-2K. A study with Kb mutants. , . . Exp. Med. 154:993 .
12 . Albert, F, M. Buferne, C. Boyer, and A.-M. SchmittVerhulst. 1982. Interactions be-
tween MHC-encoded products and cloned Tcells. I. Fine specificity of induction of
proliferation and lysis. Immunogenetics. 16:533.
13 . Nisizawa, T, B. M. Ewenstein, H. Uehara, D. McGovern, and S. G. Nathenson. 1981.
Biochemical studies on the H-2K antigens of the MHC mutant bm1. Immunogenetics. 12:33 .
14. Schulze, D. H., L. P. Pease, S. S. Geier, A. A. Reyes, L. A. Sarmiento, R. B. Wallace,
and S. G. Nathenson. 1983 . Comparison of the cloned H-2Kb'" variant gene with the
H-2K' gene shows a cluster of seven nucleotide differences. Proc. Natl. Acad. Sci. USA.
80:2007.
15 . Sherman, L. A. 1980. Dissection of the B10.D2 anti-H-2Kb cytolytic T lymphocyte
receptor repertoire. J Exp. Med. 151:1386.
16. Lopez de Castro, J. A., J . A. Barbosa, M. S. Knangel, P A. Biro, and J. L. Strominger.
1985. Structural analysis of the functional sites of class I HLA antigens. Immunol. Rev.
85:149.
17 . Jordan, B. R., D. Caillol, M. Damotte, T. Delovitch, I? Ferrier, B. Kahn-Perles, F
Kourilsky, C. Layet, P Le Bouteiller, F A. Lemonnier, M. Malissen, C. N'Guyen, J.
Sire, R. Sodoyer, T Strachan, and J. Trucy. 1985. HLA class I genes: from structure
to expression, serology, and function. Immunol. Rev. 84:73.
18. Melief, C. J. M., L. P. de Waal, M. Y. van der Meulen, P. Ivanyi, and R. W. Melvold.
1981. Fine specificity of cytotoxic T lymphocytes directed against H-2L°. Immunogenetics.
12:75.
19. De Waal, L. P., S. G. Nathenson, and C . J. M. Melie£ 1983. Direct demonstration that
cytotoxic T lymphocytes recognize conformational determinants and not primary amino
acid sequences. J . Exp. Med. 158:1720.
20. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C.
Wiley. 1987. Structure of the human classI histocompatability antigen, HLA-A2. Nature
(Loud.). 329:506.
21 . Bjorkman, P J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C.
Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class
I histocompatability antigens. Nature (Lond.). 329:512.
22. Allen, H., D. Wraith, P Pala, B. Askonas, and R. A. Flavell. 1984. Domain interactions
of H-2 class I antigens alter cytotoxic Tcell recognition sites. Nature (Loud.). 309:279.
23 . Arnold, B., H.-G. Burgert, U. Hamann, G. Hammerling, U. Kees, and S. Kvist. 1984.
Cytolytic T cells recognize the two amino-terminal domains of H-2K antigens in tandem
in influenza A infected cells. Cell. 38:79.
24. Arnold, B., U. Horstmann, W Kuon, H.-G. Burgert, G. J. Hammerling, and S. Kvist.
1985. Alloreactive cytolytic T-cell clones preferentially recognize conformational deter-
minants on histocompatability antigens: analysis with genetically engineeredhybrid an-
tigens, Proc. Nad. Acad. Sci. USA. 82 :7030.
25. Stroynowski, I., S. Clark, L. A. Henderson, L. Hood, M. McMillan, and J. Forman.
1985. Interaction of al with a2 region in class I MHC proteins contributes determinants
recognized by antibodies and cytotoxic T cells. J Immunol. 135:2160.
26. Murre, C., E. Choi, J. Weis, J. G. Seidman, K. Ozato, L. Liu, S.J. Burakoff, and C. S.MANN ET AL.
￿
323
Reiss. 1984. Dissection of serological and cytolytic T lymphocyte epitopes on murine
major histocompatability antigens by a recombinant H-2 gene separating the first two
external domains.J. Exp. Med 160:167.
27. McCluskey J., L. Boyd, M. Foo,J. Forman, D. H. Margulies, andJ. A. Bluestone. 1986.
Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal
domains: functional T cell recognition requires preservation offine structuraldeterminants.
J Immunol. 137:3881.
28. Forman, J. 1987. Determinants on major histocompatibility complex class I molecules
recognized by cytotoxic T lymphocytes. Adv. Immunol. 41:135.
29. Mann, D. W.,1. Stroynowski, L. Hood, andJ. Forman. 1987. Cytotoxic T lymphocytes
from mice with soluble classI Q10 molecules in their serum are not tolerant to membrane-
bound Q10. J Immunol. 138:240.
30 . Mann, D. W., and F. Forman. 1988. A third class I major histocompatibility complex
antigen encoded by a gene in the D-region of the H-2d haplotype recognized by cytotoxic
T lymphocytes. Immunogenetics. In press.
31 . Straus, D. S., 1. Stroynowski, S. G. Schiffer, and L. Hood. 1985 . Expression of hybrid
class I genesofthe major histocompatibility complex in mouse L cells. Proc. Nad. Acad.
Sci. USA. 82:6245.
32 . McLaughlinTaylor, E., C. G. Miyada, M. McMillan, and R. B. Wallace. 1988. Direct
demonstration of critical amino acid residues required for CTL allorecognition of H-2
class I antigens. Proc. Natl. Acad. Sci. USA. 85:3085.
33 . Koeller, D., R. Lieberman, J-i. Miyazaki, E. Appella, K. Ozato, D. W. Mann, and J.
Forman. 1987. Introduction of H-2Dd determinants into the H-2Ld antigen by site-
directed mutagenesis. J. Exp. Med. 166:744.
34. Pease, L. R., D. H. Schulze, G. M. Pfaffenbach, and S. G. Nathenson. 1983. Sponta-
neous H-2 mutants provide evidence that a copy mechanism analogous to gene conver-
sion generates polymorphism in the major histocompatibility complex. Proc. Natl. Acad
Sci. USA. 80:242.
35. Weiss, E. H., A. Mellor, L. Golden, K. Fahrner, E. Simpson,J. Hurst, and R. A. Flavell.
1983. The structure of a mutant H-2 gene suggests that the generation ofpolymorphism
in H-2 genes may occur by gene conversion-like events. Nature (Load.). 301:671.
36. Mellor, A. L., E. H. Weiss, M. Kress, G. Jay, and R. A. Flavell. 1984. A nonpolymorphic
class I gene in the murine major histocompatibility complex. Cell. 36:139.
37. Kress, M., D. Cosman, G. Khoury and G. Jay. 1983. Secretion of a transplantation-
related antigen. Cell. 34:189.
38. Devlin, J. J ., A. M. Lew, R. A. Flavell, and J. E. Coligan. 1985. Secretion of a soluble
class I molecule encoded by the Q10 gene of the C57BLA0 mouse. EMBO (Eur. Mol.
Biol. Organ.)J 4:369.
39. Nabholz, M., H. Young, T. Meo, V. Miggiano, A. Rijnbeek, and D. C. Shreflfer. 1975 .
Genetic analysis of an H-2 mutant, B6.C-H-211a, using cell-mediated lympholysis: T and
B-cell dictionaries for histocompatibility determinants are different. Immunogenetics. 1:457.
40. Hunt, P., and D. W Sears. 1983. CTL cross-reactivities reveal shared immunodominant
determinants created by structurally homologous regions of MHC class I antigens.J.
Immunol . 130:1439.
41 . Sears, D. W., and P Hunt. 1983. Structural localization ofclassI MHC antigenic deter-
minants by genetically mapping cytotoxic T-lymphocyte cross-reactives. Transplant. Proc.
15:2064.
42. Golding, H., J. Bluestone, M. L. Satz, D. Singer, and A. Singer. 1985. Generation of
primary murine CTL specific for allogeneic and xenogeneic MHC determinants upon
stimulation with murine L cells transfected with class I genes. J Immunol. 134:3557.
43. Stephan, D., H. Sun, K. F. Lindahl, E. Meyer, G. Hammerling, L. Hood, and M. Stein-324
￿
STRUCTURE OF A CYTOTOXIC T LYMPHOCYTE EPITOPE
metz. 1986. Organization and evolution of D region class I genes in the mouse major
histocompatibility complex. J. Exp. Med. 163:1227.
44. Cowan, E. P, M. L. Jelachich, J. E. Coligan, and W. E. Biddison. 1987. Site-directed
mutagenesis ofan HLA-A3 gene identifies amino acid 152 as crucial for major histocom-
patability complex-restricted and alloreactive cytotoxic T-lymphocyte recognition. Proc.
Nail. Acad. Sci. USA. 84:5014.
45 . Wu, T. T, and E. A. Kabat. 1970. An analysis of the sequences of the variable regions
of Bence Jones proteins and myeloma light chains and their implications for antibody
complimentarily. J. Exp. Med. 132:211.
46 . Ozato, K., G. A. Evans, B. Shykind, D. H . Margulies, andJ. G. Seidman. 1983. Hybrid
H-2 histocompatibility gene products assign domains recognized by alloreactive T cells.
Proc. Nat. Acad. Sci. USA. 80:2040.
47 . Stroynowski, I., A. Orn, R. S. Goodenow, M. McMillan, J. Forman, P R. Brayton,
J. Frelinger, and L. Hood. 1984. Cytotoxic T lymphocytes recognize determinants on
the BALB/c-H-2Ld molecule controlled by al and a2 but not a3 external domains. Im-
munogenetics. 20:141.
48. Forman, J ., and J. Klein. 1975. Immunogenetic analysis of H-2 mutations II. Cellular
immunity to the H-2da mutation. J Immunol. 115 :711.
49. Sun, Y. H., R. S. Goodenow, and L. Hood. 1985. Molecular basis of the dml mutation
in the major histocompatibility complex of the mouse. A D/L hybrid gene. J. Exp. Med.
162:1588.
50. Clark, S. S., and J. Forman. 1983. Allogeneic and associative recognition determinants
of H-2 molecules. Transplant. Proc. 15:2090.
51 . De Waal, L. P, W. M. Kast, R. W Melvold, and C . J. M. Melief. 1983 . Regulation
of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants.
J. Immuno. 130:1090.
52 . Clark, S. S., S. Geier, S. G. Nathenson, and J. Forman. 1985. Analysis of associative
recognition determinants on class I H-2K6 mutant molecules. Immunogenetics. 22:391.
53. Berzofsky, J. A. 1985. Intrinsic and extrinsic factors in protein antigenic structure. Science
(Wash. DC). 229:932.
54. DeLisi, C., andJ. A. Berzofsky. 1985 . Tcell antigenic sites tend to be amphipathic struc-
tures. Proc. Nat. Acad. Sci. USA. 82:7048.
55. Berkower, I., G. K. Buckenmeyer, and J. A. Berzofsky. 1986. Molecular mapping of
a histocompatibility-restricted immunodominant T cell epitope with synthetic and nat-
ural peptides: implications for T cell antigenic structure. J Immuno. 136:2498.
56. Klein, J., and F Fiqueroa. 1986. The evolution ofclass I MHC genes. Immunol. Today. 7:41.